Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Venneri

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of the American College of Cardiology|May 27, 2026
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR studyAdam Ioannou, Rishi Patel, Josephine Mansell, et al.
JACC. Cardiovascular Imaging|July 10, 2025
Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid CardiomyopathyYousuf Razvi, Aldostefano Porcari, David F Hutt, et al.
Circulation. Cardiovascular Imaging|February 12, 2026
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial IntelligenceAdam Ioannou, Michel G Khouri, Takeshi Kitai, et al.
European Journal of Heart Failure|January 22, 2024
Myocardial perfusion in cardiac amyloidosisLiza Chacko, Tushar Kotecha, Adam Ioannou, et al.
Circulation|November 3, 2022
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 YearsAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
European Heart Journal|October 14, 2022
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatmentAna Martinez-Naharro, Rishi Patel, Tushar Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Journal of the American College of Cardiology|March 26, 2024
Stratifying Disease Progression in Patients With Cardiac ATTR AmyloidosisAdam Ioannou, Francesco Cappelli, Michele Emdin, et al.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of the American College of Cardiology|May 27, 2026
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders - The EXCALIBUR studyAdam Ioannou, Rishi Patel, Josephine Mansell, et al.
JACC. Cardiovascular Imaging|July 10, 2025
Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid CardiomyopathyYousuf Razvi, Aldostefano Porcari, David F Hutt, et al.
Circulation. Cardiovascular Imaging|February 12, 2026
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial IntelligenceAdam Ioannou, Michel G Khouri, Takeshi Kitai, et al.
European Journal of Heart Failure|January 22, 2024
Myocardial perfusion in cardiac amyloidosisLiza Chacko, Tushar Kotecha, Adam Ioannou, et al.
Circulation|November 3, 2022
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 YearsAdam Ioannou, Rishi K Patel, Yousuf Razvi, et al.
European Heart Journal|October 14, 2022
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatmentAna Martinez-Naharro, Rishi Patel, Tushar Kotecha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging SystemJahanzaib Khwaja, Amy A Kirkwood, Paolo Milani, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Journal of the American College of Cardiology|March 26, 2024
Stratifying Disease Progression in Patients With Cardiac ATTR AmyloidosisAdam Ioannou, Francesco Cappelli, Michele Emdin, et al.
European Heart Journal|May 22, 2023
Conventional heart failure therapy in cardiac ATTR amyloidosisAdam Ioannou, Paolo Massa, Rishi K Patel, et al.
Pageof 7